pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-628 |
Genomic Coordinates | chr15: 55372940 - 55373034 |
Synonyms | MIRN628, hsa-mir-628, MIR628 |
Description | Homo sapiens miR-628 stem-loop |
Comment | The mature sequence shown here represents the most commonly cloned form from large-scale cloning studies . |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-628-3p | ||||||||||||||||||||||||||||
Sequence | 61| UCUAGUAAGAGUGGCAGUCGA |81 | ||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||
Experiments | Microarray | ||||||||||||||||||||||||||||
Editing Events in miRNAs |
|
DRVs in miRNA |
|
||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | TGFBRAP1 | ||||||||||||||||||||
Synonyms | TRAP-1, TRAP1, VPS3 | ||||||||||||||||||||
Description | transforming growth factor beta receptor associated protein 1 | ||||||||||||||||||||
Transcript | NM_001142621 | ||||||||||||||||||||
Other Transcripts | NM_004257 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on TGFBRAP1 | |||||||||||||||||||||
3'UTR of TGFBRAP1 (miRNA target sites are highlighted) |
>TGFBRAP1|NM_001142621|3'UTR 1 AAAGCTTGGCCCAAGGGTGCGAGGGGAACTCCGAGTTCTTTCTGAGCCTGCTGGACATGAAGAGCAGATGACCACCATGC 81 TCTGTGTCAGCCAGGACGAAGGGAGACATCTGGGTGCCAGGGAGCCTTCCGTCCATACGCAACAAGGACTCCTCGCTGCT 161 GACCAGGCTCTATGAATGTACATGGAATGACCAGGCTCTATGAATGTACATGGAAAACCCCTAAAAATCCCCAAAACAGA 241 AACATACAAGAGTTCACCTGTCCAGGTACATAGTAATCCAAGACAGAGGTCTACTTTGAAAAAAAAAAAAAGGGAGTCTT 321 CCTCATGCAGTCCAGACCCAGGTGGGGGATCCCCCACCACCCCCACACTCCAACCTTTAGACTCATGTTTGCACTGGAAA 401 CGTGGCTTCACCATGGCTGGCGACAAAGTCCTCTCTTGCCTGGGTGAGTGGCGAGGGCACAGAGCCTCATGGGGGTCAGC 481 CTTGCCCTCCTGCAGAAACACGTTCTCCATCCACGCCGCTCACTCATGGGCCCATTTCCCAGGGTTACCTCGTGGGCTCT 561 GCCTTTGCCCTCAGAAACGGCTGACCCTGGAGAAGTACCTTTGTTCCTTCTTTCTTCCTCTCCGGCTCTCAGCTCCCAAA 641 AGATTCTGCCTTGTGTACCCAAGCACTCACTCTTGGGTGAACTAATGCTTCTGGCTGCCTAGCAAGTGAAGATCTGTTGA 721 GAAACTGAGAACGCTCCAAGAGAGAAGCTGCTCTCCCCTCCTTGAAGAAGCCGCGGACACGGGAAACCCACGGCGGGCAA 801 GGGCCCAGCTGTGTGCTCCTTTCCTGTCATGGCATCTGCTGATTTGAAACTCCATGACGAACACGTTGAACTAAACATTT 881 TTATTTAAATTTGTATCATGTTCGTAGTTGCTCTCTTGTTGAGAGAGTCATCTGTCCTGTTTGTTAGGGGTATTTTTTCT 961 TGTTAAAATGTATCTCCTGTTGAATACTCGGGAAATTCAAAGGGAAGTGTGGTCAGCACACACTGAGCGTTCTTTTCTGG 1041 AGAGGCCGGTTTTAGCCTCGTACCTTTAGCAGGACCGACAGCGGGTGGAAGGGCCCGTGTGCTGGATGGGGGTGTCGCCT 1121 CCTGGATGGCACACCCTCCCGAGGACATCCAGACAGGCTGTGTCACCCTCCAGCACTTTATGTGCCTGCTCTGAGGTGTC 1201 CTGAACACACAGCAACGGCCTCTCCTTCATCACAGGCCGGGGATTCCTTTTGTGTTTCTGTATAACATCGATGACGAGCT 1281 GAAGCTGTTGTCACTTCACTGCCCTCTTTGGAATTTCTTCATTGTGCTGACTGATTCTATTAGGGGCTAACAATAAAGGC 1361 AGTCTACCCACTACTATCATGCTTGGGAAACAAGCGTCAGCTTGTACATATGACAAGAGAGGACCCTGAATACACCCTCT 1441 CTTCATCAGCCCAAGCCTTACTGAGGTGGGATGAAGACCTCATTCTCTGTTCTTTAAAACATGTTTCGTGAACTAATATT 1521 GGTCCATGTATTTTTTGTCCTTTTGGGACTCTAAGTGGGTCAAGAAGCAAAAACATCCATGTGTTGTTTGGGGGGAATTG 1601 GCACCATTTTTTCCTGACTATGTTTCAATTAACTAAAGAATAAATGATGAAGAAATTCTCCTTGTAGCACAACTGTATGC 1681 TGTGTAAATTGGTGTGAGCTCAAAGCCCAGTCATGTGTTTTACCTGTGGGTGACTCTGTTGTAGAATGGTCATATTACTG 1761 CATATGTTATCATGACAACTTGTGAGTTTGAGTTTATATTTCTCAAAGAACAAGTTACCCGTATATGCAACATTGCGCCA 1841 TTAAAAGCTTATTTCTCTGTACACAAAATGGGTAAAATCTTGAAAAAACTTAGTAATTTCTCATTCCTAACACACAGACA 1921 GAGTCTCACTCTGTCACCCAGGCTGGAGTGCAGTGGCGCAATCTCGGCTCACTGCAACCTCCACCTCCTGGGTTCAAGCG 2001 ATTCTGCTGCCTCAGCCTCCCGAGTAGCTGGGACTACAGGTGCATGCCACCACGCCCAGCTAATTTTTGTATTTTTAGTA 2081 GAGACGGGGTTTCACCATGTTGGCCAGGATGGTCTCGGTCTCCTGACCTCGTGATCTGCCTGCCTCGGCCTCCCAAAGTG 2161 CTGGGATTACAGGCGTGAGCCACTGCGCCCAGCCAACACTAGTCATTTTTATTTTTTCACTGAACATTGATCAATACTCT 2241 AAAATGTTTGTCATCCTTTAGAATAATGGGAATTAAAGTTGAGCAGTTTTCCATCTCTACCAAATCCTTCACCACAAGCA 2321 GCATTCTATTACAGTATGAAGAATTGTCTCATATGTTAAAACTGTACTTTTCTCTAACCTTTCTCTCACTCCTACAAGGC 2401 CCTTTTCTCAAATCATATTTCTGAGAGAAATGTATGGTTCTTTCTCACAGGCCTGCTGATTTGTAACTGTGCCATCGAAT 2481 AGAGCAATTAGATCCATCAGACCTTTTTCCCCTCATTAGGTTCAGTGGAACCATTCTGGTTAAAACAGCATGAACTGAAC 2561 TCAGTTTACATTCATATTCTATGGGCAATACCATTTGGTTTTTGGAACTGTTTATCTGCTGTTCCCTATCAAGTATTAAT 2641 GTAGGGATGTCACTCAGGCTGCGTTGCACTGGGCTGAGTTCAACTGCGACGCTCTCACTGACGCGTGCTTACATGTGCTT 2721 CTCACTTCCGGAGCACAGGCAGGTGGCTGCGGGGTCCCAGCTCTGAATGGATGCCCATGATGCAACTGGGGCAGCCCTTG 2801 CTTTTTGCTTGCTCTCCCACAGAAACCTTTGTCCTTGCAACTTTATCCTTTGTCCCGATTGGGTCCCAGATACACAAAAT 2881 GTACAAATGTAAACTTGCTCATTTTATTAAAATTCTTTTAGTTCTTTGTTCTTTCTGTAATTTTTTAAAATAAAAATTGC 2961 CTTGATGGAGTGATGGTTTTCACTCGCACCATAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
miRNA:Target | ---- | |||||||||
Validation Method |
|
|||||||||
Conditions | Flp-In T-REx 293-hAGO1 cells | |||||||||
Location of target site | 3'UTR | |||||||||
Original Description (Extracted from the article) |
...
Validation of interactions identified by CLASH suppports their reliability.
... - Helwak A; Kudla G; Dudnakova T; Tollervey D, 2013, Cell. |
|||||||||
miRNA-target interactions (Provided by authors) |
|
|||||||||
Article |
- Helwak A; Kudla G; Dudnakova T; Tollervey D - Cell, 2013
MicroRNAs (miRNAs) play key roles in gene regulation, but reliable bioinformatic or experimental identification of their targets remains difficult. To provide an unbiased view of human miRNA targets, we developed a technique for ligation and sequencing of miRNA-target RNA duplexes associated with human AGO1. Here, we report data sets of more than 18,000 high-confidence miRNA-mRNA interactions. The binding of most miRNAs includes the 5' seed region, but around 60% of seed interactions are noncanonical, containing bulged or mismatched nucleotides. Moreover, seed interactions are generally accompanied by specific, nonseed base pairing. 18% of miRNA-mRNA interactions involve the miRNA 3' end, with little evidence for 5' contacts, and some of these were functionally validated. Analyses of miRNA:mRNA base pairing showed that miRNA species systematically differ in their target RNA interactions, and strongly overrepresented motifs were found in the interaction sites of several miRNAs. We speculate that these affect the response of RISC to miRNA-target binding.
LinkOut: [PMID: 23622248]
|
MiRNA-Target Expression Profile | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
27 hsa-miR-628-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT039584 | CDC14A | cell division cycle 14A | 1 | 1 | ||||||||
MIRT039585 | AGO1 | argonaute 1, RISC catalytic component | 2 | 3 | ||||||||
MIRT039586 | TGFBRAP1 | transforming growth factor beta receptor associated protein 1 | 1 | 1 | ||||||||
MIRT039587 | LRP6 | LDL receptor related protein 6 | 1 | 1 | ||||||||
MIRT071876 | BTF3L4 | basic transcription factor 3 like 4 | 2 | 2 | ||||||||
MIRT097443 | JMY | junction mediating and regulatory protein, p53 cofactor | 2 | 4 | ||||||||
MIRT100100 | ABT1 | activator of basal transcription 1 | 2 | 8 | ||||||||
MIRT147692 | CBX4 | chromobox 4 | 2 | 2 | ||||||||
MIRT408248 | PURA | purine rich element binding protein A | 2 | 2 | ||||||||
MIRT442047 | LRAT | lecithin retinol acyltransferase | 2 | 2 | ||||||||
MIRT444412 | RAB3IP | RAB3A interacting protein | 2 | 2 | ||||||||
MIRT452599 | REPIN1 | replication initiator 1 | 2 | 2 | ||||||||
MIRT469515 | RBFOX2 | RNA binding protein, fox-1 homolog 2 | 2 | 8 | ||||||||
MIRT498192 | AKR1B10 | aldo-keto reductase family 1 member B10 | 2 | 2 | ||||||||
MIRT500151 | CREBBP | CREB binding protein | 2 | 2 | ||||||||
MIRT507319 | FAM60A | SIN3-HDAC complex associated factor | 2 | 6 | ||||||||
MIRT508343 | ZNF273 | zinc finger protein 273 | 2 | 6 | ||||||||
MIRT520480 | TRIM13 | tripartite motif containing 13 | 2 | 2 | ||||||||
MIRT522461 | MMP16 | matrix metallopeptidase 16 | 2 | 4 | ||||||||
MIRT547116 | PHLPP2 | PH domain and leucine rich repeat protein phosphatase 2 | 2 | 2 | ||||||||
MIRT548675 | CRNKL1 | crooked neck pre-mRNA splicing factor 1 | 2 | 2 | ||||||||
MIRT553756 | TARBP2 | TARBP2, RISC loading complex RNA binding subunit | 2 | 4 | ||||||||
MIRT559437 | ARSJ | arylsulfatase family member J | 2 | 2 | ||||||||
MIRT610490 | GPC4 | glypican 4 | 2 | 2 | ||||||||
MIRT644682 | TMCO1 | transmembrane and coiled-coil domains 1 | 2 | 2 | ||||||||
MIRT658214 | FBXO21 | F-box protein 21 | 2 | 2 | ||||||||
MIRT756083 | TP53 | tumor protein p53 | 4 | 1 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|